Inspire Medical Systems Inc. logo

Inspire Medical Systems Inc.

INSP | NYSE
Chart Builder DCF Calculator
$75.72
-$1.06 (-1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$75.70
-$0.02 (-0.03%)
After-hours: Sep 21, 2026, 7:13 PM ET

Company Profile

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.

Key Executives

Name Position
Timothy Herbert Founder, Chairman, Chief Executive Officer & President
Melissa J. Mann Chief People Officer
Andreas Henke Executive VP International & MD
Bryan K. Phillips Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary
Carlton W. Weatherby Chief Strategy and Growth Officer
Ezgi Yagci Vice President of Investor Relations
Ivan Lubogo SVP of Strategic Sales
Jason Kelly Chief Operations & Innovation Officer
John C. Rondoni Chief Product & Innovation Officer
Joseph E. Sander Senior Vice President of U.S. Sales
Matthew J. Osberg Executive VP & CFO
Megan Rowekamp Director of Financial Reporting

Latest SEC Filings

Date Type Title
Sep 02, 2026 4 Filing
Aug 13, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 11, 2026 4 Filing
Aug 04, 2026 4 Filing
Aug 03, 2026 10-Q Quarterly Report
Aug 03, 2026 8-K Current Report
Jul 31, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 28, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 27, 2026 4 Filing
View All SEC Filings
Inspire Medical Systems Inc.
Inspire Medical Systems Inc. logo
Country United States
IPO Date May 2, 2018
Industry Medical - Devices
Sector Healthcare
Employees 1,333
CEO Timothy Herbert

Contact Details

5500 Wayzata Boulevard Golden Valley, Minnesota 55416 United States

Stock Details

Ticker Symbol INSP
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001609550
CUSIP Number 457730109
ISIN Number US4577301090
SIC Code 3841

© 2026 bestshares.com. All rights reserved.